Results published of remdesivir, COVID-19 trial
May 28, 2020
According to the study, the drug improved recovery time and decreased the number of deaths.
Faculty present their innovations at virtual pitch day
May 22, 2020
Nine UT Health San Antonio clinicians and scientists pitched their innovations in the President’s Translational and Entrepreneurial Research Fund (PTEF) virtual forum held May 20.
Second phase of clinical trial for promising COVID-19 drug begins
May 15, 2020
Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.
Don’t let COVID-19 keep you from getting stroke care
May 13, 2020
Even during the COVID-19 pandemic, patients should never hesitate to call an ambulance if they have signs of a stroke
Cognition and gait speed often decline together, study shows
May 4, 2020
A study published by UT Health San Antonio researchers found that thinking and walking often parallel each other in determining a person’s health trajectory.
FDA gives emergency authorization to COVID-19 drug
May 4, 2020
Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 in a randomized clinical trial.